Titre : Vibrio

Vibrio : Questions médicales fréquentes

Termes MeSH sélectionnés :

Vancomycin
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vibrio : Questions médicales les plus fréquentes", "headline": "Vibrio : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vibrio : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vibrio" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vibrionaceae", "url": "https://questionsmedicales.fr/mesh/D014737", "about": { "@type": "MedicalCondition", "name": "Vibrionaceae", "code": { "@type": "MedicalCode", "code": "D014737", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vibrio alginolyticus", "alternateName": "Vibrio alginolyticus", "url": "https://questionsmedicales.fr/mesh/D044149", "about": { "@type": "MedicalCondition", "name": "Vibrio alginolyticus", "code": { "@type": "MedicalCode", "code": "D044149", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.030" } } }, { "@type": "MedicalWebPage", "name": "Vibrio cholerae", "alternateName": "Vibrio cholerae", "url": "https://questionsmedicales.fr/mesh/D014734", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae", "code": { "@type": "MedicalCode", "code": "D014734", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vibrio cholerae non-O1", "alternateName": "Vibrio cholerae non-O1", "url": "https://questionsmedicales.fr/mesh/D044163", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae non-O1", "code": { "@type": "MedicalCode", "code": "D044163", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100.075" } } }, { "@type": "MedicalWebPage", "name": "Vibrio cholerae O1", "alternateName": "Vibrio cholerae O1", "url": "https://questionsmedicales.fr/mesh/D041241", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae O1", "code": { "@type": "MedicalCode", "code": "D041241", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100.151" } } }, { "@type": "MedicalWebPage", "name": "Vibrio cholerae O139", "alternateName": "Vibrio cholerae O139", "url": "https://questionsmedicales.fr/mesh/D041242", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae O139", "code": { "@type": "MedicalCode", "code": "D041242", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Vibrio mimicus", "alternateName": "Vibrio mimicus", "url": "https://questionsmedicales.fr/mesh/D044164", "about": { "@type": "MedicalCondition", "name": "Vibrio mimicus", "code": { "@type": "MedicalCode", "code": "D044164", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.500" } } }, { "@type": "MedicalWebPage", "name": "Vibrio parahaemolyticus", "alternateName": "Vibrio parahaemolyticus", "url": "https://questionsmedicales.fr/mesh/D014736", "about": { "@type": "MedicalCondition", "name": "Vibrio parahaemolyticus", "code": { "@type": "MedicalCode", "code": "D014736", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.590" } } }, { "@type": "MedicalWebPage", "name": "Vibrio vulnificus", "alternateName": "Vibrio vulnificus", "url": "https://questionsmedicales.fr/mesh/D041261", "about": { "@type": "MedicalCondition", "name": "Vibrio vulnificus", "code": { "@type": "MedicalCode", "code": "D041261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.900" } } } ], "about": { "@type": "MedicalCondition", "name": "Vibrio", "alternateName": "Vibrio", "code": { "@type": "MedicalCode", "code": "D014733", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jaime Martinez-Urtaza", "url": "https://questionsmedicales.fr/author/Jaime%20Martinez-Urtaza", "affiliation": { "@type": "Organization", "name": "Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Barcelona, Spain." } }, { "@type": "Person", "name": "Jessica L Jones", "url": "https://questionsmedicales.fr/author/Jessica%20L%20Jones", "affiliation": { "@type": "Organization", "name": "U.S. Food and Drug Administration Gulf Coast Seafood Laboratory 1 Iberville Drive UNITED STATES Dauphin Island AL 36528 2514068136." } }, { "@type": "Person", "name": "William C Walton", "url": "https://questionsmedicales.fr/author/William%20C%20Walton", "affiliation": { "@type": "Organization", "name": "2Auburn University Shellfish Laboratory, School of Fisheries, Aquaculture, and Aquatic Sciences, Auburn University, 150 Agassiz Street, Dauphin Island, AL 36528, USA." } }, { "@type": "Person", "name": "Julia C van Kessel", "url": "https://questionsmedicales.fr/author/Julia%20C%20van%20Kessel", "affiliation": { "@type": "Organization", "name": "Biology Department, Indiana University, Bloomington, Indiana, USA jcvk@indiana.edu." } }, { "@type": "Person", "name": "Blake Ushijima", "url": "https://questionsmedicales.fr/author/Blake%20Ushijima", "affiliation": { "@type": "Organization", "name": "Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Case analysis of hepatotoxicity caused by vancomycin.", "datePublished": "2024-06-04", "url": "https://questionsmedicales.fr/article/38831463", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13256-024-04574-4" } }, { "@type": "ScholarlyArticle", "name": "An Unusual Case of Low Vancomycin Exposure Despite Extremely High Vancomycin Doses Accompanied by Renal Toxicity: A Grand Round.", "datePublished": "2023-01-02", "url": "https://questionsmedicales.fr/article/36728568", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/FTD.0000000000001061" } }, { "@type": "ScholarlyArticle", "name": "Clinical outcome of combination of vancomycin and ceftaroline versus vancomycin monotherapy for treatment of methicillin resistant Staphylococcus aureus bloodstream infection.", "datePublished": "2024-10-28", "url": "https://questionsmedicales.fr/article/39468491", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12879-024-10107-7" } }, { "@type": "ScholarlyArticle", "name": "Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin's clinical durability.", "datePublished": "2024-08-29", "url": "https://questionsmedicales.fr/article/39207957", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.ppat.1012422" } }, { "@type": "ScholarlyArticle", "name": "Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections.", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37067406", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/cmr.00059-22" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Bactéries", "item": "https://questionsmedicales.fr/mesh/D001419" }, { "@type": "ListItem", "position": 3, "name": "Proteobacteria", "item": "https://questionsmedicales.fr/mesh/D020560" }, { "@type": "ListItem", "position": 4, "name": "Gammaproteobacteria", "item": "https://questionsmedicales.fr/mesh/D020563" }, { "@type": "ListItem", "position": 5, "name": "Vibrionaceae", "item": "https://questionsmedicales.fr/mesh/D014737" }, { "@type": "ListItem", "position": 6, "name": "Vibrio", "item": "https://questionsmedicales.fr/mesh/D014733" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vibrio - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vibrio", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vibrio", "description": "Comment diagnostiquer une infection à Vibrio ?\nQuels tests sont utilisés pour identifier Vibrio ?\nLes tests sérologiques sont-ils utiles ?\nPeut-on diagnostiquer Vibrio par PCR ?\nQuels symptômes orientent vers un diagnostic de Vibrio ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Vancomycin&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vibrio", "description": "Quels sont les symptômes d'une infection à Vibrio ?\nLa diarrhée est-elle toujours présente ?\nLes infections à Vibrio causent-elles de la fièvre ?\nY a-t-il des symptômes graves associés ?\nLes symptômes apparaissent-ils rapidement ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Vancomycin&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vibrio", "description": "Comment prévenir les infections à Vibrio ?\nLe lavage des mains est-il important ?\nLes vaccinations existent-elles contre Vibrio ?\nFaut-il éviter certains aliments ?\nLes voyages augmentent-ils le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Vancomycin&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vibrio", "description": "Quel est le traitement principal pour Vibrio ?\nQuels antibiotiques sont efficaces contre Vibrio ?\nLa réhydratation est-elle toujours nécessaire ?\nLes traitements sont-ils différents selon le type de Vibrio ?\nLes probiotiques aident-ils dans le traitement ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Vancomycin&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vibrio", "description": "Quelles complications peuvent survenir avec Vibrio ?\nLa déshydratation est-elle une complication fréquente ?\nLes infections à Vibrio peuvent-elles être mortelles ?\nY a-t-il des risques pour les personnes immunodéprimées ?\nLes infections cutanées sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Vancomycin&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vibrio", "description": "Quels sont les principaux facteurs de risque pour Vibrio ?\nLes personnes âgées sont-elles plus à risque ?\nLe diabète augmente-t-il le risque d'infection ?\nLes personnes vivant près de l'eau sont-elles plus exposées ?\nLes voyages dans des zones endémiques sont-ils risqués ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Vancomycin&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection à Vibrio ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des cultures bactériennes à partir d'échantillons de selles." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier Vibrio ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de culture et des tests biochimiques spécifiques sont utilisés." } }, { "@type": "Question", "name": "Les tests sérologiques sont-ils utiles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques ne sont généralement pas utilisés pour Vibrio." } }, { "@type": "Question", "name": "Peut-on diagnostiquer Vibrio par PCR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la PCR peut être utilisée pour détecter l'ADN de Vibrio dans les échantillons." } }, { "@type": "Question", "name": "Quels symptômes orientent vers un diagnostic de Vibrio ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes gastro-intestinaux comme la diarrhée aiguë peuvent indiquer une infection." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection à Vibrio ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée, vomissements, douleurs abdominales et fièvre." } }, { "@type": "Question", "name": "La diarrhée est-elle toujours présente ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, la diarrhée est fréquente mais pas systématique dans les infections à Vibrio." } }, { "@type": "Question", "name": "Les infections à Vibrio causent-elles de la fièvre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fièvre peut accompagner les infections à Vibrio, mais ce n'est pas toujours le cas." } }, { "@type": "Question", "name": "Y a-t-il des symptômes graves associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes graves peuvent inclure déshydratation et choc septique dans les cas sévères." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître rapidement, souvent dans les 24 heures suivant l'infection." } }, { "@type": "Question", "name": "Comment prévenir les infections à Vibrio ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de consommer des fruits de mer crus ou mal cuits et lavez-vous les mains." } }, { "@type": "Question", "name": "Le lavage des mains est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le lavage des mains réduit le risque d'infection par Vibrio et d'autres pathogènes." } }, { "@type": "Question", "name": "Les vaccinations existent-elles contre Vibrio ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccin efficace contre les infections à Vibrio." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, évitez les fruits de mer crus, surtout en période de chaleur ou d'épidémies." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où Vibrio est endémique augmente le risque d'infection." } }, { "@type": "Question", "name": "Quel est le traitement principal pour Vibrio ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est la réhydratation, souvent accompagnée d'antibiotiques si nécessaire." } }, { "@type": "Question", "name": "Quels antibiotiques sont efficaces contre Vibrio ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des antibiotiques comme la doxycycline et l'azithromycine sont souvent utilisés." } }, { "@type": "Question", "name": "La réhydratation est-elle toujours nécessaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la réhydratation est cruciale, surtout en cas de diarrhée sévère." } }, { "@type": "Question", "name": "Les traitements sont-ils différents selon le type de Vibrio ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement peut varier selon le type de Vibrio et la gravité de l'infection." } }, { "@type": "Question", "name": "Les probiotiques aident-ils dans le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques peuvent aider à restaurer la flore intestinale, mais ne remplacent pas le traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Vibrio ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la déshydratation sévère, le choc septique et l'insuffisance rénale." } }, { "@type": "Question", "name": "La déshydratation est-elle une complication fréquente ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la déshydratation est une complication courante, surtout en cas de diarrhée sévère." } }, { "@type": "Question", "name": "Les infections à Vibrio peuvent-elles être mortelles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, dans les cas graves, les infections à Vibrio peuvent être mortelles sans traitement rapide." } }, { "@type": "Question", "name": "Y a-t-il des risques pour les personnes immunodéprimées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées sont à risque accru de complications graves." } }, { "@type": "Question", "name": "Les infections cutanées sont-elles possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Vibrio peut causer des infections cutanées, surtout après des blessures en milieu aquatique." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour Vibrio ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'immunodépression." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de complications graves liées à Vibrio." } }, { "@type": "Question", "name": "Le diabète augmente-t-il le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut augmenter le risque d'infections graves à Vibrio." } }, { "@type": "Question", "name": "Les personnes vivant près de l'eau sont-elles plus exposées ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être plus exposées aux infections à Vibrio, surtout en été." } }, { "@type": "Question", "name": "Les voyages dans des zones endémiques sont-ils risqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où Vibrio est courant augmente le risque d'infection." } } ] } ] }

Sources (1253 au total)

Case analysis of hepatotoxicity caused by vancomycin.

Although the correlation between liver toxicity and vancomycin is generally considered low, it has been observed that the use of vancomycin can lead to abnormal liver function indicators, such as elev... Patients with liver function injury who received vancomycin treatment at the Third Xiangya Hospital of Central South University and Hunan Maternal and Child Health Hospital between 2016 and 2021 were ... Of the 4562 patients who received vancomycin, 17 patients were finally included, with an incidence rate of 0.37%. Of these patients, 12 were male (70.6%) and 5 were female (29.4%), ranging in age from... Although the study concluded that the incidence of liver injury was not high, the liver toxicity of vancomycin should still be considered and liver function indicators should be monitored during the c...

Clinical outcome of combination of vancomycin and ceftaroline versus vancomycin monotherapy for treatment of methicillin resistant Staphylococcus aureus bloodstream infection.

The role of combination therapies for serious methicillin-resistant Staphylococcus aureus (MRSA) infections is widely debated.... This retrospective cohort study included adults with MRSA bacteraemia treated between January 1, 2013, to December 31, 2022. Patients receiving combination therapy with vancomycin and ceftaroline were... Of 57 patients included, 37 (65%) were in the combination group. The overall intensive care unit admission rate was 63.2% (36/57) and the Pitt Bacteraemia Score was 1 [0-4] at the time of diagnosis. T... The results of this study are limited by a retrospective observational design; however, combination of vancomycin and ceftaroline for MRSA bacteraemia was not associated with lower bacteraemia recurre...

Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin's clinical durability.

Vancomycin has proven remarkably durable to resistance evolution by Staphylococcus aureus despite widespread treatment with vancomycin in the clinic. Only 16 cases of vancomycin-resistant S. aureus (V...

Pharmacokinetic variability of vancomycin in patients with nosocomial meningitis.

High doses of vancomycin are required early in the treatment of nosocomial meningitis. However, the dosage is often reduced later during treatment, irrespective of renal function. This study was desig... This study included 17 patients who received vancomycin for nosocomial bacterial meningitis at the Tokyo Women's Medical University Yachiyo Medical Center from April 2013 to May 2020. All patients had... The relative error between the predicted serum vancomycin concentration and the measured value was significantly higher in the later period than in the early period. In 13 patients who did not have th... This study suggests that the clinical condition and inflammatory response of a patient with meningitis influence the pharmacokinetics of vancomycin. Therefore, the vancomycin dosage for the treatment ...

Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium.

Antimicrobial resistance is a major public health threat, and there is an urgent need for new strategies to address this issue. In a recent study, a library screening strategy was developed in which a...

Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.

This study aimed to investigate the prevalence of Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA, VRSA) and Vancomycin-Resistant Enterococcus (VRE) of hospital food samples in Mashh...